Think Amyloid! Cardiac Amyloidosis for Community Cardiologists

Register now for ASNC’s new “Think Amyloid! Cardiac Amyloidosis for Community Cardiologists” series!

This series will provide community-based healthcare providers with education on diagnosing, treating, and providing effective multidisciplinary management of patients with known or suspected cardiac amyloidosis.

Each session will be 2 hours with short didactic and case-based discussion and offers up to 2 CME credits.

Dates of the Series:

May 21, 2025, from 5:30pm to 7:30pm ET
June 10, 2025, from 5:30pm to 7:30pm ET
June 19, 2025, from 5:30pm to 7:30pm ET

Register Now

Learning Objectives:

• Describe signs and symptoms of ATTR-CM, diagnostic work-up, and the therapeutic landscape of amyloidosis.
• Explain the importance and testing to rule out light chain amyloidosis.
• Recognize polyneuropathy in diagnosing patients.
• Discuss the importance of genetic testing in effective patient management.
• Identify high-risk scenarios for suspected ATTR-CM.
• Define current and evolving treatments for ATTR-CM and when to prescribe.
• Develop strategies for appropriate patient management and multidisciplinary needs within a center of excellence.

Credits

Participants can earn up to 2 CME credits per webinar.

Registration

Register for the entire 3-part series!

Complimentary for ASNC Members
$25 for Non-members

Agenda

May 21, 2025 – Part 1: Confirming the Diagnosis of ATTR-CM

5:30 pm — Welcome and Logistics
Faculty: Melissa Lyle, MD, and David Wolinsky, MD, MASNC

5:35 pm — Keynote: ATTR-CM: A Systemic Disease
Faculty: Jerry Estep, MD

5:55 pm — Suspecting ATTR-CM
Faculty: Grace Lin, MD

6:10 pm — Maximizing the Value of ECHO Interpreting and Reporting
Faculty: Craig Asher, MD

6:25 pm — Bone Scintigraphy: The Cornerstone for Diagnosis
Faculty: Wael A. Jaber, MD, FASNC

6:40 pm — Cardiac Comorbidities and Risk of ATTR-CM
Faculty: David Snipelisky, MD

6:55 pm — Challenging Diagnostic Cases
Faculty: David Wolinsky, MD, MASNC, and panelists

7:20 pm — Q&A
Faculty: Panelists

7:30 pm — Adjourn

June 10, 2025 – Part 2: State of the Art Treatment in ATTR-CM

5:30 pm — Welcome, Logistics, Highlights from Part 1
Faculty: David Wolinsky, MD, MASNC

5:35 pm — Keynote: The Evolution of Disease Modifying Therapy: What Are our Options in 2025
Faculty: Melissa Lyle, MD

6:00 pm — Atrial Fibrillation: Drugs, Ablation and Devices in the setting of ATTR-CM
Faculty: Christopher McLeod, MB, ChB, PhD

6:15 pm — Treatment of the Octogenarian with ATTR-CM
Faculty: David Wolinsky, MD, MASNC

6:30pm — Identifying Disease Progression-Imaging, Biomarkers, or Clinical Assessment
Faculty: Dia Smiley, DO

6:45 pm — Advanced Heart Failure Therapy – Drugs and Devices or Hospice
Faculty: David Snipelisky, MD

7:00 pm — Cases with Audience Participation
Faculty: Melissa Lyle, MD, and David Wolinsky, MD, MASNC

7:20 pm — Q&A
Faculty: Panelists

7:30 pm — Adjourn

June 19, 2025 – Part 3: Establishing a Center of Excellence

5:30 pm — Welcome, Logistics, Highlights from Part 2
Faculty: Melissa Lyle, MD, and David Wolinsky, MD, MASNC

5:35 pm — Identification of V122i ATTR in the African -America Population: We Have to Do Better
Faculty: M. Trejeeve Martyn, MD, MSc

5:50 pm — Neuropathy and ATTR-CM – Yes, or No? Treatment?
Faculty: Elizabeth Mauricio, MD

6:05 pm — MGUS vs Al Amyloid: When to Call Hematology
Faculty: Chakra Chaulagain, MD

6:20 pm — Transplant: Who and When
Faculty: Melissa Lyle, MD

6:35 pm — PET Imaging and Potential Role to Guide Therapy
Faculty: Dia Smiley, DO

6:50 pm — Clinical Trials: Potential New Therapies
Faculty: Melissa Lyle, MD

7:05 pm — Multidisciplinary Approach to ATTR-CM – Putting it All Together to Establish an Amyloid Program in the Community
Faculty: Jose Nativi Nicolau, MD, MSc

7:20 pm — Multidisciplinary Cases
Faculty: Panelists

7:35 pm — Q&A and Closing Remarks
Faculty: Melissa Lyle, MD, and David Wolinsky, MD, MASNC

Supported by unrestricted educational grants from BridgeBio and Pfizer.